ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 98 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $63,866 | +15.7% | 78,848 | 0.0% | 0.00% | – |
Q1 2023 | $55,194 | +197021.4% | 78,848 | +100.0% | 0.00% | – |
Q4 2022 | $28 | -99.9% | 39,424 | +33.7% | 0.00% | – |
Q3 2022 | $45,000 | +55.2% | 29,484 | -0.3% | 0.00% | – |
Q2 2022 | $29,000 | -32.6% | 29,584 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -72.1% | 29,584 | 0.0% | 0.00% | – |
Q4 2021 | $154,000 | -11.5% | 29,584 | -0.7% | 0.00% | – |
Q3 2021 | $174,000 | -29.8% | 29,784 | -3.2% | 0.00% | -100.0% |
Q2 2021 | $248,000 | -2.7% | 30,779 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $255,000 | +0.8% | 30,679 | -8.0% | 0.00% | 0.0% |
Q4 2020 | $253,000 | -31.2% | 33,340 | -3.3% | 0.00% | 0.0% |
Q3 2020 | $368,000 | +8.6% | 34,482 | -15.3% | 0.00% | 0.0% |
Q1 2020 | $339,000 | -56.0% | 40,694 | -10.7% | 0.00% | -66.7% |
Q4 2019 | $770,000 | -11.2% | 45,569 | -2.4% | 0.00% | 0.0% |
Q3 2019 | $867,000 | -20.8% | 46,669 | -2.5% | 0.00% | -25.0% |
Q2 2019 | $1,095,000 | +2.9% | 47,854 | -5.5% | 0.00% | 0.0% |
Q1 2019 | $1,064,000 | +79.4% | 50,635 | -1.9% | 0.00% | +33.3% |
Q4 2018 | $593,000 | -57.5% | 51,590 | -15.1% | 0.00% | -40.0% |
Q3 2018 | $1,395,000 | +3.3% | 60,770 | +0.4% | 0.01% | -16.7% |
Q2 2018 | $1,350,000 | +30.6% | 60,550 | +33.8% | 0.01% | +50.0% |
Q1 2018 | $1,034,000 | -15.4% | 45,245 | -3.0% | 0.00% | -20.0% |
Q4 2017 | $1,222,000 | +16.6% | 46,660 | -0.1% | 0.01% | 0.0% |
Q3 2017 | $1,048,000 | – | 46,685 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |